Thanks, Mark. Turning to Slide 6, I will highlight our first quarter results. On a consolidated basis, non-GAAP operating earnings were $421 million or $1.30 per share. The only notable item in the quarter was below plan alternative investment income, which reduced earnings by $13 million after tax. Adjusting for this, non-GAAP earnings per share was $1.35 per share. As Mark mentioned, our results this quarter were impacted by elevated mortality claims in our individual life insurance block, which reduced earnings per share by about $0.20 relative to our normal expectations. If mortality had been in line with budget, earnings per share excluding notable items would have increased 12% year-over-year. GAAP net income was $63 million in the quarter. This is lower than our non-GAAP operating earnings due to non-economic hedging impacts, which are offset in OCI. Total assets under management and administration rose 3% year-over-year to $1 trillion, but they declined on a sequential basis as a result of weaker equity markets in the first quarter. Our reported book value per share ex AOCI was $27.62 in the quarter. As a reminder, GAAP accounting requires us to carry AB at book value, which we believe materially understates shareholders’ equity at the EQH level and inflates our leverage ratio. We added new disclosure this quarter to highlight book value per share including our ownership in AB at market value. The adjusted book value per share was $39.96 as of March 31 and our leverage ratio would have been nearly seven points lower. This difference will become more notable moving forward, given our increased ownership in a bit. I’ll provide some further details on our segment level earnings drivers on Slide 7. Mortality claims in our individual life insurance block came in approximately 80 million above our expectations on a pre-tax basis. Our block is concentrated in higher face value policies and has limited reinsurance coverage. In this quarter, we experienced an abnormally high number of large claims. While hard to be definitive, we believe a harsh flu season was a contributing factor. The CDC has classified this as the first high severity flu season since 2017, 2018, and the cumulative hospitalization rate is the highest observed since 2011. The poor experience this quarter and recent volatility in our individual life earnings underscores why we made a strategic decision to reinsure 75% of our life block to RGA. This transaction which is on track to close mid-year, will significantly reduce our mortality exposure and enhance our focus on our core growth engines. I also want to spend a minute discussing our individual retirement earnings, which declined year-over-year despite strong net flows. Results were pressured by a few items. The first is expenses, which reflects higher seasonal compensation costs for benefits, payroll taxes, and long-term incentive pay-outs due to 2024 bonus payments. In addition, the growth in commission pay-outs reflects strong sales volume, particularly in Equitable Advisors, where not all pay-outs can be capitalized in DAC. We expect compensation expense to normalize in the second quarter, but commissions will depend on sales levels and the mix by channel. Turning to revenues, we continue to see steady growth in spread earnings or NIM driven by positive RILA net flows. However, fee income was negatively affected by a decline in average separate account assets and fewer fee days in the first quarter. Given the equity market decline we’ve seen so far in April, this will likely remain a near-term headwind offsetting growth in NIM. Keep in mind that our traditional VA block has a higher return on assets than our RILA block. So reduced fee income will also pressure the segment’s return on assets. Overall, our individual retirement business produces a high return on capital and consistent cash flows. While the benefit of our strong organic growth takes some time to emerge in results, we expect steady growth in earnings over time. First quarter results for Group Retirement and Wealth Management businesses were in line with our expectations, which included some anticipated revenue and expense seasonality. Both businesses had positive organic growth with $192 million of Group inflows and $2 billion of Wealth Management advisory net flows. Advisory productivity improved 8%, which is a good leading indicator of future growth. AB had a strong quarter with positive net flows across each of its distribution channels, a relatively stable base fee rate and good expense control. The business had an adjusted margin of 33.7% for the quarter, up 340 basis points from the first quarter ‘24. While the market decline in April could pressure near-term flows and margins, AB has a diversified asset mix and a differentiated distribution, including its private wealth business, leadership position in Asia and its partnership with Equitable, all position it well for long-term success. Finally, our alternative investments portfolio had a 6% annualized return in the first quarter consistent with our guidance. Current market volatility makes projecting future returns difficult, but we expect them to remain below our 8% to 12% long-term target in the second quarter. We will provide a more specific update later in the quarter when we have better visibility. Turning to Slide 8, we will highlight Equitable’s capital management program. During the quarter, we returned $335 million to shareholders, including $261 million of share repurchases, which translates to an 80% pay-out ratio. This is above our 60% to 70% guidance range, primarily due to lower earnings as a result of unfavorable mortality. Over the past year, we have reduced our share count by approximately 7%, helping to drive growth in earnings per share. We also plan to increase our quarterly cash dividend on common shares by 13% to $0.27 in May pending Board approval. We ended the quarter with $2.2 billion of cash and liquid assets at holdings, up from $1.8 billion at the end of the fourth quarter. During the first quarter, we received about $200 million of cash flows from subsidiaries and issued $500 million of new hybrid securities in March. In April, we invested $760 million to increase our ownership in AB and used $283 million of the hybrid proceeds to tender for some of our existing Series B preferred equity. As a result, we currently have $1.1 billion of cash at the holding company, comfortably above our $500 million target. On Slide 9, we highlight our macro sensitivities both from an earnings and balance sheet standpoint. The earnings sensitivities are consistent with what we’ve highlighted previously even as we’ve grown our business. Every 10% change in equity markets has about $150 million of annual impact on after-tax earnings. Turning to interest rates, a 50 basis point change in long-term rates has about a $40 million to $45 million impact on our annual earnings. We have a relatively limited sensitivity to changes in short-term rates as we have a similar exposure to floating rate assets and liabilities. The primary impact is on our cash sweep revenue in our Wealth Management business where a 100 basis points change in the Fed funds rate equates to about a 70 basis points change in our sweep yield. Cash sweeps only drive about 20% of Wealth Management earnings and less than 2% of total company earnings, so this is very manageable. Keep in mind that these sensitivities are prior to any management actions such as expense controls. We still have about $50 million of our targeted $150 million in annual expense saves that will earn in by 2027 and Equitable has demonstrated a strong expense discipline in prior periods of market volatility. Turning to the balance sheet, as Mark discussed, we fully hedge the equity market and interest rate exposure associated with our product guarantees. Therefore, our capital position has little sensitivity to markets. The primary risk that we take is credit exposure through our general account investment portfolio. We have updated our credit stress test for the portfolio as of year-end 2024 and the result is illustrated on the right-hand side of the slide. For fixed maturity securities, the stress is calibrated to the global financial crisis like scenarios. We also assume a minus 40% equity market decline, which negatively affects the value of our private equity and other alternative investments. The impact of such a severe stress would be a 50 point reduction in our RBC ratio. Currently, this would take us from about 425%, down to 375%. We expect the Life Reinsurance transaction to increase our RBC ratio by 75 to 100 points after paying an extraordinary dividend to the holding company, which will provide significant additional capital cushion if needed. Our insurance subsidiaries only produced about 50% of our holding company cash flows, so we would still generate meaningful cash even if we needed to reduce our insurance dividends for a period. Therefore, we feel confident that we are well positioned to withstand even a severe credit downturn. Putting it all together, we feel we’re well positioned to navigate a period of macro volatility and have expense levers in place if markets remain challenging. Finally on Slide 10, we lay out the timeline and key milestones for our Life Reinsurance transaction. To reiterate, the transaction is on track to close in mid-2025 and will free up over $2 billion of capital. We’ve planned to deploy these proceeds in a prudent and timely manner and as I mentioned earlier, we used approximately $760 million of holdco liquidity to acquire $19.7 million of AB Holding units, increasing our ownership in AllianceBernstein from 62% to 69%. Post close, we expect to bring an extraordinary dividend to the holding company and we’ll remain committed to executing $500 million of incremental EQH share repurchases on top of our 60% to 70% pay-out ratio. This leaves nearly $1 billion of remaining resources. Given the pullback in our share price, additional share buybacks beyond the $500 million are certainly something we’ll look at and this would likely need to be accompanied by some debt repayment to manage our leverage ratios. We will also be watching the broader market environment. This transaction provides a lot of financial flexibility, which is a significant positive in periods of uncertainty. Therefore, it makes sense to exercise some patience, but we remain committed to making the reinsurance transaction accretive to both earnings and cash flow per share. Now let me turn the call back over to Mark. Mark?